The Prostate

Cover image for Vol. 72 Issue 2

1 February 2012

Volume 72, Issue 2

Pages 117–232

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse (pages 117–128)

      Sophie Giusiano, Stéphane Garcia, Claudia Andrieu, Nelson Javier Dusetti, Cyrille Bastide, Martin Gleave, Colette Taranger-Charpin, Juan Lucio Iovanna and Palma Rocchi

      Version of Record online: 2 MAY 2011 | DOI: 10.1002/pros.21412

    2. Imaging prostate cancer lymph node metastases with a multimodality contrast agent (pages 129–146)

      Mary A. Hall, Sunkuk Kwon, Holly Robinson, Pier-Anne Lachance, Ali Azhdarinia, Ranjani Ranganathan, Roger E. Price, Wenyaw Chan and Eva M. Sevick-Muraca

      Version of Record online: 2 MAY 2011 | DOI: 10.1002/pros.21413

    3. Early onset prostate cancer has a significant genetic component (pages 147–156)

      Ethan M. Lange, Claudia A. Salinas, Kimberly A. Zuhlke, Anna M. Ray, Yunfei Wang, Yurong Lu, Lindsey A. Ho, Jingchun Luo and Kathleen A. Cooney

      Version of Record online: 2 MAY 2011 | DOI: 10.1002/pros.21414

    4. Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers (pages 157–164)

      Russell Z. Szmulewitz, Elizabeth Chung, Hikmat Al-Ahmadie, Silver Daniel, Masha Kocherginsky, Aria Razmaria, Gregory P. Zagaja, Charles B. Brendler, Walter M. Stadler and Suzanne D. Conzen

      Version of Record online: 11 MAY 2011 | DOI: 10.1002/pros.21416

    5. Alternol exerts prostate-selective antitumor effects through modulations of the AMPK signaling pathway (pages 165–172)

      Eddie D. Yeung, Alex Morrison, Daniel Plumeri, Jingying Wang, Chao Tong, Xiaoyan Yan and Ji Li

      Version of Record online: 2 MAY 2011 | DOI: 10.1002/pros.21417

    6. Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences (pages 173–180)

      Ping Tang, Wei Du, Keji Xie, Jingao Fu, Hui Chen, Wenjun Yang and Judd W. Moul

      Version of Record online: 2 MAY 2011 | DOI: 10.1002/pros.21418

    7. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum (pages 186–192)

      Alberto Briganti, Nazareno Suardi, Paolo Capogrosso, Niccolò Passoni, Massimo Freschi, Ettore di Trapani, Andrea Gallina, Umberto Capitanio, Firas Abdollah, Manuela Tutolo, Marco Bianchi, Andrea Salonia, Luigi Filippo Da Pozzo, Francesco Montorsi and Patrizio Rigatti

      Version of Record online: 2 MAY 2011 | DOI: 10.1002/pros.21420

    8. Pathological significance and predictive value for biochemical recurrence of c-Fes expression in prostate cancer (pages 201–208)

      Yasuyoshi Miyata, Shin-ichi Watanabe, Tomohiro Matsuo, Tomayoshi Hayashi, Hideki Sakai, Jim W. Xuan, Peter A. Greer and Shigeru Kanda

      Version of Record online: 11 MAY 2011 | DOI: 10.1002/pros.21422

    9. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality (pages 209–216)

      Irene M. Shui, Jennifer R. Stark, Kathryn L. Penney, Fredrick R. Schumacher, Mara M. Epstein, Michael J. Pitt, Meir J. Stampfer, Rulla M. Tamimi, Sara Lindstrom, Howard D. Sesso, Katja Fall, Jing Ma, Peter Kraft, Edward Giovannucci and Lorelei A. Mucci

      Version of Record online: 11 MAY 2011 | DOI: 10.1002/pros.21423

    10. The role of Pax2 in mouse prostate development (pages 217–224)

      Ben Xu, Arun Hariharan, Sabita Rakshit, Gregory R. Dressler and Deneen M. Wellik

      Version of Record online: 18 MAY 2011 | DOI: 10.1002/pros.21424

    11. Androgens repress expression of the f-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells (pages 225–232)

      Jingting Jiang, Yunqian Pan, Kevin M. Regan, Changping Wu, Xueguang Zhang, Donald J. Tindall and Haojie Huang

      Version of Record online: 31 MAY 2011 | DOI: 10.1002/pros.21430